UA42527A - Method for treating chronic hepatitis c - Google Patents

Method for treating chronic hepatitis c

Info

Publication number
UA42527A
UA42527A UA2001032030A UA200132030A UA42527A UA 42527 A UA42527 A UA 42527A UA 2001032030 A UA2001032030 A UA 2001032030A UA 200132030 A UA200132030 A UA 200132030A UA 42527 A UA42527 A UA 42527A
Authority
UA
Ukraine
Prior art keywords
interferon
chronic hepatitis
courses
treatment
treating chronic
Prior art date
Application number
UA2001032030A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ольга Ігоревна Коліуш
Ольга Игоревна Колиуш
Павло Спиридонович Аршинов
Павел Спиридонович Аршинов
Original Assignee
Кримський Державний Медичний Університет Ім. С.І. Георгієвського
Крымский Государственный Медицинский Университет Им. С.И. Георгиевского
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кримський Державний Медичний Університет Ім. С.І. Георгієвського, Крымский Государственный Медицинский Университет Им. С.И. Георгиевского filed Critical Кримський Державний Медичний Університет Ім. С.І. Георгієвського
Priority to UA2001032030A priority Critical patent/UA42527A/en
Publication of UA42527A publication Critical patent/UA42527A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The method for treating the chronic hepatitis C comprises the intramuscular injections of recombinant alpha-2b interferon (the domestically produced interferon preparation named Laferon) at a dose 3 millions IU thrice a week. The interval between the courses of the treatment is up to 6 weeks. The biologic preparations produced by Heel company (Engistol, Hepel, Ecchinacea compositum) are used between the courses of interferon. The overall duration of the treatment is 10-12 months.
UA2001032030A 2001-03-27 2001-03-27 Method for treating chronic hepatitis c UA42527A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2001032030A UA42527A (en) 2001-03-27 2001-03-27 Method for treating chronic hepatitis c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2001032030A UA42527A (en) 2001-03-27 2001-03-27 Method for treating chronic hepatitis c

Publications (1)

Publication Number Publication Date
UA42527A true UA42527A (en) 2001-10-15

Family

ID=74223212

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001032030A UA42527A (en) 2001-03-27 2001-03-27 Method for treating chronic hepatitis c

Country Status (1)

Country Link
UA (1) UA42527A (en)

Similar Documents

Publication Publication Date Title
ATE539744T1 (en) INHIBITORS OF SERINE PROTEASE, IN PARTICULAR HEPATITIS C VIRUS NS3-NS4A PROTEASE, WITH A CONDENSED RING SYSTEM
DE60119968D1 (en) Hepatitis c tripeptid inhibitoren
TW200716095A (en) Method of treating interferon non-responders using HCV protease inhibitor
SG159385A1 (en) Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
MXPA02012443A (en) 3 -PRODRUGS OF 2 -DEOXY-bgr;-L-NUCLEOSIDES.
MX2021002147A (en) Treatment of hepatitis delta virus infection with interferon lambda.
MXPA05009786A (en) Composition for administration of iron for the treatment of restless legs syndrome.
IL151981A0 (en) Method of treating hepatitis delta viral infection
UA42527A (en) Method for treating chronic hepatitis c
BR0213823A (en) Method of Administration of a Thymosin Alpha Peptide 1
LT2002123A (en) Novel interferon for the treatment of multiple sclerosis
GR3037021T3 (en) Method of treating hepatitis c in non-responders to interferon treatment
EA200800729A1 (en) TREATMENT OF NEVERITIS NOSE NERVE
EA202190594A1 (en) TREATMENT OF VIRAL INFECTION OF HEPATITIS DELTA INTERFERON LAMBDA
HK1056117A1 (en) Treatment of hepatitis C with thymosin and pegylated interferon
ATE348628T1 (en) TREATING HEPATITIS C WITH THYMOSIN, INTERFERON AND RIBAVIRIN
MX2022004399A (en) Methods to treat hepatitis delta viral infections.
NO961685L (en) Method of treating hepatitis B carriers with minimal disease
UA49531A (en) Method for treating cholestatic variant of acute viral hepatitis b in the setting of tuberculosis
UA36093A (en) Method for treating chronic bronchitis
MXPA05008425A (en) Regimen of administration for nelfinavir.
UA39708A (en) Method for treating postamputation pain syndrome
MY109685A (en) Method for treating hepatitis b carriers with minimal disease